Α1 Adrenergic Receptors in Serum and Saliva of Patients With Oral Squamous Cell Carcinoma Publisher Pubmed

Summary: Study suggests higher salivary α1 adrenergic receptors in oral cancer patients indicate cellular changes. Could these serve as diagnostic markers? #Oncology #SalivaBiomarkers

Gholizadeh N¹ ; Mohebbi AH² ; Mirzaiidizgah I³ ; Sheykhbahaei N¹
Source: Clinical and Translational Oncology Published:2021

Abstract

Background: Neurotransmitters released from the sympathetic nervous system attach to the adrenergic receptors on the surface of tumoral cells in response to stress, and alter the expression of genes programming cellular activity. This study aimed to assess the expression of α1 adrenergic receptors in the serum and saliva of patients with oral squamous cell carcinoma (OSCC) compared with healthy controls. Materials and methods: In this case–control study, serum and stimulated and unstimulated saliva samples were collected from 26 OSCC patients and 26 healthy controls. ELISA kits were used for measurement of the serum and salivary levels of α1 adrenergic receptors. Results: The level of α1 adrenergic receptors was significantly higher in the stimulated and unstimulated saliva of OSCC patients than healthy controls (P = 0.000). However, their serum level was not significantly different between the two groups (P = 0.389). The serum level of α1 adrenergic receptors significantly increased by an increase in OSCC grade. No significant correlation was noted between the serum and salivary levels of α1 adrenergic receptors in OSCC patients. The salivary level of α1 adrenergic receptors was significantly higher in patients with tumors located in the gingiva, compared with other sites. Conclusion: Significantly higher salivary level of α1 adrenergic receptors in OSCC patients compared with healthy controls, and no significant difference in their serum level between the two groups may indirectly indicate the over-expression of these receptors in OSCC cells, compared with normal oral mucosa. Further studies and particularly histological analyses are required to confirm this finding. © 2021, Federacion de Sociedades Espanolas de Oncologia (FESEO).